A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
Recruiting - Local Institution - 0026
Vancouver, British Columbia, Canada
Not, yet, recruiting - Qeii Health Sciences Centre - Victoria General Site
Halifax, Nova Scotia, Canada
Recruiting - Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Recruiting
- Local Institution - 0030
Suzhou, Jiangsu, China
Not, yet, recruiting - Local Institution - 0031
Shanghai, Shanghai Municipality, China
Not, yet, recruiting
- Universitaetsklinikum Carl Gustav Carus Dresden
Dresden, Germany
Recruiting - Universitaetsklinikum Hamburg-Eppendorf
Hamburg, Germany
Recruiting - Universitaetsklinikum Heidelberg
Heidelberg, Germany
Recruiting
- Alexandra General Hospital of Athens
Athens, Attikí, Greece
Recruiting - Evangelismos General Hospital of Athens
Athens, Attikí, Greece
Recruiting
- St. Olavs Hospital
Trondheim, Sør-Trøndelag, Norway
Recruiting - Sykehusapoteket Ull
Oslo, Norway
Recruiting
- Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Recruiting - Hospital Universitario de Salamanca - Complejo Asistencial Universitario de Salamanca
Salamanca, Spain
Recruiting
- University College London Hospital
London, England, United Kingdom
Recruiting - Royal Marsden Hospital (sutton)
London, Sutton, United Kingdom
Recruiting - the Christie Nhs Foundation Trust
Manchester, United Kingdom
Recruiting
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Recruiting - Yale New Haven Hospital-Smilow Cancer Center
New Haven, Connecticut, United States
Recruiting - Hackensack University Medical Center
Hackensack, New Jersey, United States
Recruiting - University of Texas Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 7 Oct 2025
- Primary completion
- 31 May 2027
- Completion
- 3 Jun 2027
- Last update posted
- 28 May 2026
- Registered enrollment
- 62
- Registry id
- NCT06988488
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.